Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-905-0 | CAS number: 111-76-2
Immunotoxicity
Administrative data
Description of key information
NOAEL (21 day oral, dw)) > 444mg/kg/day (female)
NOAEL (21 day, oral, dw) > 500mg/kg/day (male)
NOAEL (2 day, oral, gav) > 400mg/kg/day (male)
NOAEL (4 day, oral, gav) = 1000mg/kg/day (female)
Key value for chemical safety assessment
Effect on immunotoxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
Additional information
In a study to evaluate the effects on the immune system of 2 -butoxyethanol (2BE) exposure, male and female rats were exposed through drinking water exposure to doses of up to 450 -500mg/kg/day for 21 days. Measures of cellular and humural immune function were assessed, including NK cell function, deleyd type hypersensitivity reaction, IL2, interferon and serum IgG production. No effects were seen on the thymus. Natural killer cytotoxic responses were enhanced in male and female rats treated with the low dose of 2BE, but only by around 6 -13% and the effect was not seen in the high dose animals. No effect on antibody production nor DTH reactions was observed. The authors concluded that the immune system is not a sensitive target for 2BE. This was confirmed in another study to assess the response of rats antibody response to TNP-LPS when treated acutely with 2 -butoxyethanol at doses up to 400mg/kg, which showed no evidence of immunosuppressive effects at doses which produced lethal general toxicity.
In a study to assess the effects on the immune system of 2-butoxyethanol, mice were subject to repeat dermal application over a period of 4 days at doses up to 1500mg/kg. The study reported increased splenic cellularity and spleen/body weight ratios at the highest dose. Reduced splenic T cell proliferative and mixed lymphocyte responses were also reported but without a clear dose response relationship. There was no effect on the thymus, on B cell proliferation, humoral immunity parameters, a cytotoxic T lymphocyte assay or NK cell activity.
The conclusion drawn from the studies available is that immunotoxicity is not an important characteristic of 2 -butoxyethanol
Justification for classification or non-classification
No biologically plausible adverse effects seen at levels below 1000mg/kg/day. No classification required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
